Repligen Corporation (RGEN)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$175.23
—
Mkt Cap $11.35B
Analyst Ratings
Buy
9
Hold
1
Sell
0
Price Target (25 analysts)
$162.43
Range $142.00 – $225.00
Implied Upside
-7.3%
Consensus $162.43 vs current $175.23